Medical News

RSS

Hypnosis may help reduce pain and suffering in metastatic breast cancer patients

Hypnosis can help alleviate the pain and suffering experienced by women being treated for breast cancer, according to a study by a University at Buffalo School of Social Work professor.

26 Feb 2010

Today's OpEds: Health summit critiques

We're told that gridlock, procedural holds, partisanship and extreme ideology are preventing members of Congress from working together. While some of this analysis is true -- Washington is petty, partisan and shortsighted -- few are acknowledging that Congress does enjoy remarkable unity in one critical area: spending beyond our means (Sen. Tom Coburn, 2/26).

26 Feb 2010

California subpoenas financial records of seven biggest insurers

"The California state attorney general's office said Thursday that it had subpoenaed financial records of California's seven largest health insurance companies as part of an investigation into whether they illegally raised customer premiums and denied payment of legitimate claims," the Los Angeles Times reports. "Prosecutors said they sought documents from Anthem Blue Cross, Aetna Health, Blue Shield of California, Cigna, Health Net, Kaiser Permanente and PacifiCare."

26 Feb 2010

Vion Pharmaceuticals' Onrigin SPA: FDA responds

VION PHARMACEUTICALS, INC. announced today that it had received a response from the U.S. Food and Drug Administration on a Special Protocol Assessment for its oncology therapeutic Onrigin™ (laromustine) Injection.

26 Feb 2010

With rate cut looming, doctors threaten to stop accepting Medicare patients

With a 21 percent Medicare reimbursement rate cut set for Monday, unless Congress acts to block it, some doctors are threatening to refuse new Medicare patients in their practices.

26 Feb 2010

Female genital mutilation reversal surgeries: Clitoraid announces second round in Trinidad

Las Vegas-based Clitoraid, a non-profit, all-volunteer organization initiated by Rael, founder and leader of the International Raelian Movement, announced Friday that its second round of female genital mutilation (FGM) reversal surgeries will take place March 2-3 in Trinidad, Colo.

26 Feb 2010

dbMotion to exhibit connected healthcare solutions at HIMSS 2010

dbMotion, a provider of health interoperability solutions, announced its participation at HIMSS 2010, March 1-4 in Atlanta, Ga., both as an exhibitor (Booth 6023) and as a featured contributor to the Interoperability Showcase—demonstrating how providers can achieve meaningful data-sharing across a range of healthcare settings. Participation in the Interoperability Showcase comes on the heels of dbMotion’s successful completion of interoperability testing at the 11th Annual IHE North American Connectathon in Chicago.

26 Feb 2010

Quest Software, HealthCast announce end-to-end clinical desktop and workflow solution

Quest Software, Inc. and HealthCast, Inc. today announced an end-to-end clinical desktop and workflow solution that simplifies and automates secure clinician access to protected healthcare information with the benefits of virtualization.

26 Feb 2010

Landauer board declares fiscal 2010 second-quarter dividend of $0.5375 per share

Landauer, Inc. announced today that its Board of Directors declared a regular quarterly cash dividend of $0.5375 per share for the second quarter of fiscal 2010.

26 Feb 2010

Fate Therapeutics named to Technology Review's 2010 TR50 most innovative companies in the world list

Fate Therapeutics, Inc. announced today that the Company was named as one of Technology Review's 2010 TR50, the publication's first annual list of the 50 most innovative companies in the world. The 2010 TR50 companies span the fields of energy, computing, the Web, biomedicine, and materials and have been evaluated based on business model, strategies for deploying and scaling up its technologies and the likelihood of success. Each company in the 2010 TR50 has excelled not only at inventing technology but also at using it to transform how we live and work.

26 Feb 2010

Arena Pharmaceuticals' lorcaserin NDA: FDA assigns PDUFA date

Arena Pharmaceuticals, Inc. announced today that the US Food and Drug Administration (FDA) has assigned a Prescription Drug User Fee Act (PDUFA) date of October 22, 2010, for the review of the lorcaserin New Drug Application (NDA). The acceptance of the lorcaserin NDA filing confirms that the application is sufficiently complete to permit a substantive review, and the PDUFA date is the goal date for the FDA to complete its review of the NDA.

26 Feb 2010

Rare Disease Day 2010: Alexion Pharmaceuticals joins NORD and EURORDIS to raise awareness

Alexion Pharmaceuticals, Inc., has joined the National Organization for Rare Disorders (NORD) and the European Organization for Rare Diseases (EURORDIS) in supporting the goals of the third annual Rare Disease Day, February 28, 2010.

26 Feb 2010

Making public policies on vaccination with limited information

"Let's say you're a public health official from the Centers for Disease Control, and you don't really know how much disease is going to be averted by vaccinating different fractions of the population," said Manski, the Board of Trustees Professor in Economics in the Weinberg College of Arts and Sciences. "Then how should you choose a policy? That's really what the paper tries to address."

26 Feb 2010

Notch-blocking drug effective against brain cancer stem cells, but more than one targeted attack needed

Working with mice, Johns Hopkins scientists who tested drugs intended to halt growth of brain cancer stem cells - a small population of cells within tumors that perpetuate cancer growth - conclude that blocking these cells may be somewhat effective, but more than one targeted drug attack may be needed to get the job done.

26 Feb 2010

Widely used biomarkers in early detection of liver cancer are not ideal: Study

Widely used biomarkers are not optimal in early detection of liver cancer, the third most common cause of cancer-related death worldwide, according to a new study published in this month's Gastroenterology.

26 Feb 2010

Bipartisan health care summit: NSBA pleads with lawmakers to move beyond rhetoric

Following today's bipartisan health care summit, NSBA is pleading with lawmakers to move beyond the rhetoric. Small-business owners across the U.S. have been struggling for years with the rising cost of health care, and need Congress to act now. For small businesses, the bottom line is addressing health care costs—not the intentions, not the proposals and most certainly not the debates.

26 Feb 2010

Salmonella-infected mice help understand how symptoms of HLH develop

A new University of Colorado at Boulder study shows mice infected with the bacteria salmonella develop clinical signs consistent with a deadly and poorly understood human inflammatory disease, a finding that may lead to new therapies.

26 Feb 2010

Mutations in MeCP2 cause autism spectrum disorder Rett Syndrome

A paper published online today in Molecular Cell proposes that Methyl CpG binding protein 2 (MeCP2) impacts the entire genome in neurons, rather than acting as a regulator of specific genes. Mutations in MeCP2 cause the autism spectrum disorder Rett Syndrome as well as some cases of neuropsychiatric problems including autism, schizophrenia and learning disabilities.

26 Feb 2010

New strategy against Botulinum toxin

A study involving the world's deadliest substance has yielded a new strategy to clear toxins from the body-which may lead to more efficient strategies against toxins that may be used in a bioterrorist event, as well as snake bites, scorpion stings, and even some important chronic diseases.

26 Feb 2010

Magellan Health Services reports net revenue of $2.64 billion for year ended December 31, 2009

Magellan Health Services, Inc. today reported net revenue of $2.64 billion, net income of $106.7 million, or $3.01 per diluted common share, and segment profit of $227.2 million for the year ended December 31, 2009.

26 Feb 2010

Medical News

Hypnosis may help reduce pain and suffering in metastatic breast cancer patients

Today's OpEds: Health summit critiques

California subpoenas financial records of seven biggest insurers

Vion Pharmaceuticals' Onrigin SPA: FDA responds

With rate cut looming, doctors threaten to stop accepting Medicare patients

Female genital mutilation reversal surgeries: Clitoraid announces second round in Trinidad

dbMotion to exhibit connected healthcare solutions at HIMSS 2010

Quest Software, HealthCast announce end-to-end clinical desktop and workflow solution

Landauer board declares fiscal 2010 second-quarter dividend of $0.5375 per share

Fate Therapeutics named to Technology Review's 2010 TR50 most innovative companies in the world list

Arena Pharmaceuticals' lorcaserin NDA: FDA assigns PDUFA date

Rare Disease Day 2010: Alexion Pharmaceuticals joins NORD and EURORDIS to raise awareness

Making public policies on vaccination with limited information

Notch-blocking drug effective against brain cancer stem cells, but more than one targeted attack needed

Widely used biomarkers in early detection of liver cancer are not ideal: Study

Bipartisan health care summit: NSBA pleads with lawmakers to move beyond rhetoric

Salmonella-infected mice help understand how symptoms of HLH develop

Mutations in MeCP2 cause autism spectrum disorder Rett Syndrome

New strategy against Botulinum toxin

Magellan Health Services reports net revenue of $2.64 billion for year ended December 31, 2009

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Latest News